A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)

✍ Scribed by Joan Maurel Santasusana; José Luis García López; Juan José Bretón García; Ana Isabel León Carbonero; Javier Gallego Plazas; Pedro Sánchez Rovira; Carlos Fernández Martos; Ma Carmen Galán Guzmán; Jesús Florián Jericó; Francisco Javier Dorta Delgado; Javier Casinello Espinosa; Marta Llanos Muñoz; Enrique Aranda Aguilar; Javier Sastre Valera; Ignacio García Ribas; Alfredo Carrato Mena

• Book ID: 110649252
• Publisher: Springer Milan
• Year: 2005
• Tongue: Spanish
• Weight: 103 KB
• Volume: 7
• Category: Article
• ISSN: 1699-048X
• DOI: 10.1007/bf02717002